Over 50 Lakh Adolescent Girls Have Received the HPV Vaccine in India

Over 50 lakh adolescent girls have received the HPV vaccine in India, a landmark figure that shows a decisive shift in the nation's healthcare research focus toward prevention at the molecular and genetic levels.

Union Minister Dr. Jitendra Singh announced the number on Friday at the RSSDI 2026 conference in Bengaluru, framing it as part of a “futuristic healthcare approach” aimed at countering metabolic disorders in younger populations.

Genome Mapping 10,000 Indians to Chart Disease Risk

This preventive pivot is underpinned by a massive genomic study. Dr. Singh highlighted the completion of genome sequencing for 10,000 Indian individuals, representing 84 distinct populations. The project has identified more than 400 genetic traits, creating a unique dataset to map disease susceptibility.

“The data offers significant opportunities for research into disease susceptibility and targeted medical interventions,” he said. This research is central to developing precise disease management in line with the vision of Viksit Bharat 2047.

Indigenous Gene Therapy Published in Top Medical Journal

India's growing capabilities in advanced medical solutions were highlighted by the publication of an indigenous gene therapy for haemophilia in the New England Journal of Medicine. Dr. Singh cited the research by Christian Medical College, Vellore, as evidence that Indian researchers are developing treatments with global applications. This progress builds on the success of the country’s indigenous DNA vaccine developed during the COVID-19 pandemic.

Over a Dozen Diabetes Projects Advance Novel Therapies

Dr. Singh also noted a robust pipeline of research into diabetes. According to Brighter Kashmir, he told the Research Society for the Study of Diabetes in India (RSSDI) 2026 conference in Bengaluru on November 20 that more than a dozen diabetes-related projects are underway.

Daily Excelsior reported these initiatives, largely from the Department of Biotechnology and CSIR, include research on a genetically modified E. coli Nissle 1917 strain engineered to produce GLP-1, a potential probiotic-based therapy for which human studies are expected.

India Emerging As Global Research Hub For Diabetes, Genetic Disorders And Advanced Healthcare: Jitendra Singh
Photo: Brighter Kashmir

Minister Calls Obesity, Diabetes Prevention a National Duty

Addressing the RSSDI 2026 inaugural session in Bengaluru, Dr. Jitendra Singh stressed that the effort requires collective action extending beyond the healthcare fraternity.

Singh added that tackling these conditions in young people must become a national priority. Coordinated efforts involving researchers, medical professionals, policymakers and society are essential, he said.

India’s Genetic Diversity Cited as Research Advantage

Singh highlighted the country’s population size and genetic diversity as a unique scientific advantage.

Photo: Daily Excelsior

The Minister said that precision medicine and molecular-level interventions are opening new avenues for understanding Type 2 diabetes and associated metabolic disorders. This focus is particularly important for prevention among younger populations, he said.

Probiotic GLP-1 Therapy Advances Toward Human Trials

The approach aims to deliver therapeutic molecules through the gastrointestinal tract as a potential probiotic-based therapy.

Human studies for this experimental treatment are expected to be undertaken. The project is among more than a dozen diabetes-related initiatives underway, largely through the Department of Biotechnology and CSIR.

The Department of Biotechnology (DBT), a department under India’s Ministry of Science and Technology established in 1986 to administer development and commercialisation in modern biology and biotechnology, serves as a primary driver for the pipeline of over a dozen diabetes research projects.

Expanding Access to Rare Disease Diagnosis and Care

Recognizing the challenges posed by rare genetic diseases, Dr. Singh said the government and ICMR are working to expand coverage. “Rare diseases impose a disproportionate burden due to diagnostic difficulties, high costs, and limited medicine availability,” he explained. This effort is complemented by the expansion of dialysis facilities in district hospitals and research focused on detecting kidney disease before symptoms appear.

“Prevention cannot be left to medical professionals alone and requires collective societal participation and greater awareness,” Dr. Singh concluded. He cautioned young people against health misinformation and unverified medical advice, urging them to seek guidance only from qualified professionals.

Photo of author

Health Desk

Health Desk at Archyde.

Apple May Delay or Cancel OLED iMac Over High Costs, The Elec Reports